Pfizer

NicOx to appeal FDA rejection

Tuesday, March 1, 2011 08:30 AM

French biotech NicOx said last week it plans to appeal the FDA’s decision to turn down its anti-inflammatory drug naproxcinod for marketing approval, Reuters reported. NicOx made the announcement at its 2010 earnings presentation.

More... »

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure

Monday, February 7, 2011 07:00 AM

A billion-dollar U.S. government drug development center, which will focus on moving potential new discoveries out of the lab and into early-phase trials, could help biopharmaceutical companies improve their success rate in developing new treatments by reducing the risk of failure in early-stage research.

More... »

Pfizer cuts jobs in Connecticut, adds in Massachusetts

Tuesday, February 1, 2011 04:18 PM

Boston Business Journal staff report

More... »

ProPublica report: big pharma paid hundreds of physicians over $100,000 in speaking fees

Monday, November 8, 2010 11:12 AM

Several doctors paid to speak on behalf of big pharmaceutical companies aren’t, in fact, the thought leaders consumers often consider them to be, but instead have been sanctioned for various forms of misconduct. And psychiatrists collect more in speaking and consulting fees from pharma companies than doctors in any other specialty.

More... »

ClinTec International launches US headquarters

Friday, July 9, 2010 07:29 AM

Glasgow, U.K.-based global clinical research organization ClinTec International has unveiled a significant expansion into the U.S., with the launch of its New York office and the appointment of Susan Pavone as Associate Director of U.S. Business Operations.

More... »

Doctor Sentenced to Six Months for Faking Study Results

Wednesday, July 7, 2010 07:57 AM

Scott Reuben, the Massachusetts doctor dubbed the medical equivalent of Bernie Madoff by Scientific American, was sentenced to six months in federal prison on June 24. His crime: faking favorable painkiller study results. Reuben pleaded guilty to one count of health care fraud in February.

More... »

Pfizer Partners with Washington University School of Medicine

Tuesday, May 25, 2010 09:26 AM

Pfizer will give scientists at Washington University School of Medicine in St. Louis unprecedented access to information on 500 pharmaceuticals and pharmaceutical candidates in a partnership that focuses on discovering new uses for existing compound.

More... »

Pfizer Warned by FDA for Inadequate Monitoring in Peds Study

Friday, April 23, 2010 07:01 AM

Pfizer received a warning letter from the U.S. Food and Drug Administration (FDA) last week, citing the pharmaceutical giant for inadequate clinical trial monitoring in the study of a pediatric drug—violations that led to the overdosing of at least 26 children.

More... »

Clinical Trial Activity in Russia Dipped in 2009

Friday, March 5, 2010 06:56 AM

According to Russia-based contract research organization (CRO) Synergy Research Group’s Annual Orange Report, Russia’s regulatory agency Federal Service on Surveillance in Healthcare and Social Development of the Russian Federation (RosZdravNadzor, RZN) approved 577 new clinical trials during 2009, 6% fewer than in 2008. Sixty percent, or 348 of the new studies, were multinational multi-center trials, down 4% from 2008.

More... »

Charges Filed in Case of Fabricated Study Results

Thursday, January 21, 2010 07:15 AM

Charges were filed in the case of Scott Reuben, the U.S. anesthesiologist who allegedly fabricated clinical trial data for at least 21 published articles. Reuben, who wrote about pain management after surgery, was formerly chief of acute pain at Bay State Hospital in Springfield, Mass.

More... »